VALIANT LABORATORIES
Back to Balance Sheet
|
VALIANT LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Non-Current Liabilities | ₹107 Cr | ₹77 Cr | ₹62 Cr |
What is the latest Total Non-Current Liabilities ratio of VALIANT LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹107 Cr |
| Mar2024 | ₹77 Cr |
| Mar2023 | ₹62 Cr |
How is Total Non-Current Liabilities of VALIANT LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹107 Cr | 39.33 | |
| Mar2024 | ₹77 Cr | 24.29 | |
| Mar2023 | ₹62 Cr | - | |
Compare Total Non-Current Liabilities of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹428.2 Cr | 3.8% | 47.8% | -11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | 3.8% |
47.8% |
-11.6% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses